# <i>EGFR</i> Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/i-egfr-i-mutation-and-resistance-of-non-small-cell-lung-cancer-to-gefitinib/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Susumu Kobayashi,Titus J. Boggon,Tajhal Dayaram,Pasi A. Jänne,Olivier Kocher,Matthew Meyerson,Bruce E. Johnson,Michael J. Eck,Daniel G. Tenen,Balázs Halmos |
| Citations | 3,956 |
| DOI | 10.1056/nejmoa044238 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.nejm.org/doi/pdf/10.1056/NEJMoa044238?articleTools=true |
| OpenAlex ID | https://openalex.org/W2003984225 |
| PMID | 15728811 |
| Type | article |
| Year | 2005 |

## Paper authors

- [Pasi A. Jänne](https://scholariq.org/researchers/pasi-a-janne/)
- [Balázs Halmos](https://scholariq.org/researchers/balazs-halmos/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer therapeutics and mechanisms](https://scholariq.org/topics/cancer-therapeutics-and-mechanisms/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.